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Abstract
Introduction Mammographic density is known to be a strong
risk factor for breast cancer. A particularly strong association
with risk has been observed when density is measured using
interactive threshold software. This, however, is a labour-
intensive process for large-scale studies.
Methods Our aim was to determine the performance of visually
assessed percent breast density as an indicator of breast
cancer risk. We compared the effect on risk of density as
measured with the mediolateral oblique view only versus that
estimated as the average density from the mediolateral oblique
view and the craniocaudal view. Density was assessed using a
visual analogue scale in 10,048 screening mammograms,
including 311 breast cancer cases diagnosed at that screening
episode or within the following 6 years.
Results Where only the mediolateral oblique view was available,
there was a modest effect of breast density on risk with an odds
ratio for the 76% to 100% density relative to 0% to 25% of 1.51
(95% confidence interval 0.71 to 3.18). When two views were
available, there was a considerably stronger association, with
the corresponding odds ratio being 6.77 (95% confidence
interval 2.75 to 16.67).
Conclusion This indicates that a substantial amount of
information on risk from percentage breast density is contained
in the second view. It also suggests that visually assessed
breast density has predictive potential for breast cancer risk
comparable to that of density measured using the interactive
threshold software when two views are available. This
observation needs to be confirmed by studies applying the
different measurement methods to the same individuals.
Introduction
Mammographic breast density is a well established risk factor
for breast cancer [1-3]. It is of particular interest because it has
a high attributable fraction and because it is amenable to
change in response to hormonal therapy, weight change, or
diet [2,4,5]. Density is a reflection of the amount of fibroglan-
dular, as opposed to fatty-replaced, tissue in the breast. There
is evidence that breast density measured quantitatively, either
as total dense area or percentage of dense area on the mam-
mogram, is a better predictor of breast cancer risk than density
classified into quantitative categories [3]. The Cumulus inter-
active threshold software is widely considered to be the 'gold
standard' tool for density measurement [1]. With Cumulus, the
reader identifies the boundaries of the breast tissue and the
threshold for dense tissue on the mammogram, and the com-
CC = craniocaudal; CI = confidence interval; MLO = mediolateral oblique; OR = odds ratio; SD = standard deviation.
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puter software calculates the total area of the breast, the total
area of dense tissue and the percentage area of dense tissue.
The absolute and percentage areas of breast tissue represent
a reduction of the three-dimensional volume of fibroglandular
tissue in the breast to a two-dimensional projection. Intuitively,
a direct measure of the volume of dense tissue is desirable.
Volumetric methods are available [6-8], although these have
not been studied as extensively as area-based methods [9].
Density, as measured using
Cumulus, currently has the strongest published relationship
with breast cancer risk [1,3]. Percent breast density is an esti-
mate of the proportion of fibroglandular tissue as opposed to
fat.
Estimating density for large numbers of mammograms using
the Cumulus software requires a major commitment of human
resources. For this reason, some large studies still use visually
assessed breast density [3,5]. Here, we report on density
assessed using a visual analogue scale in a study of 10,048
mammograms, including those of 311 breast cancer patients
in two high-throughput breast screening centres. We estimate
the effect of visually measured percent density on breast can-
cer risk and how this is modified by differences between cen-
tres and by other variables.
Materials and methods
Density was measured in the context of the Computer Aided
Detection Evaluation Trial 1 (CADET1) [10]. In this study
10,096 mammograms, including those of 315 breast cancer
cases diagnosed contemporaneously or within the following 6
years, previously double read in the UK National Breast
Screening Programme in 1996, were re-read by a single
reader assisted by the R2 ImageChecker computer aided
detection system [11]. Cancers were identified from the
screening unit records, augmented by the local cancer regis-
tries. In addition to attempting to identify cancers, the single
reader also visually estimated the percent mammographic
density. A straight line was provided on the proforma with its
right hand end corresponding to 100% density and its left
hand end to 0%. The reader examined the films and marked
the point on the line corresponding to their estimate of the
average density (of the two breasts and, where available, of
the two views). All mammograms were read in batches, a ses-
sion (morning or afternoon) at a time.
The radiologists were all experienced breast screening read-
ers, attaining the UK breast screening programme standard of
reading at least 5,000 screening mammograms per year. They
did not receive special training in density measurement.
Data on density was available in 10,048 cases (99.5%),
including 311 breast cancers diagnosed either at the original
1996 screen or subsequently. The single reader was not one
of the original two readers, and was not aware of the final diag-
nosis or of the previous reading results at the time of scoring
the density. The mean age at the original screen was 57 years
(standard deviation [SD] = 4.8 years) The age range was from
50 to 84 years, with 96% being aged 50 to 64 years (in the
UK programme at the time, women aged 50 to 64 years were
regularly invited but older women were entitled to be screened
on request).
Local research ethics committee approval was obtained,
informed consent was not required and all mammograms were
anonymized.
The study took place in two screening centres, Aberdeen and
Manchester. In each centre, the re-reading duties were shared
between four radiologists. Density was coded as a percentage
of the bright, opaque area on the breast image. The associa-
tion of density with risk was assessed using logistic regression
[12]. Variation between centres and readers was analyzed by
subgroup analyses using logistic regression and by consider-
ing mean and SD of density by reader and case status (can-
cer/noncancer). We estimated the odds ratios (ORs)
associated with percent density both as a continuous variable
and classified into the six categories described by Boyd and
coworkers [2] (0%, 1% to 10%, 11% to 25%, 26% to 50%,
51% to 75%, and 76% to 100% dense), but combining the
two lowest categories because none of the cancer patients
had 0% density. In addition, we investigated potential con-
founders of density, including age of screenee, size, node sta-
tus and grade of the cancers, and number of mammographic
views. The population attributable fraction was calculated
using the formula quoted by Breslow and Day [13].
It should be noted that this research was not intended to
assess the correlation between visually measured and
machine-measured density. The main object was to quantify
the association of visually determined density with risk, and
identify variables that modify or qualify the association.
Results
Table 1 shows numbers of subjects, and mean and SD density
by detection mode. The highest average density on the
screening radiograph was observed for interval cancers
occurring within 1 year of the 1996 screen.
Table 2 shows the numbers of cancers and noncancers clas-
sified into five density categories, and the corresponding logis-
tic regression OR estimates and 95% confidence intervals
(CIs) adjusted for age. The results are shown for all subjects
and then for each centre separately. The overall results sug-
gest a significant effect of density on breast cancer risk, with
a threefold risk for density greater than 75% compared with
10% or less. This, however, conceals a highly significant het-
erogeneity of the effect between centres (P < 0.001). The
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effect of density on risk was very strong in Manchester and
weak in Aberdeen.
The Aberdeen screenees were on average 3 months older
than the Manchester women. However, neither age of scree-
nee nor tumour features accounted for the heterogeneity
between centres (data available from the authors). Number of
views was, however, associated with the predictive potential
of density. Table 3 shows the age adjusted effect of density on
risk as estimated from one view and from two views. Two
views were available in 2,912 cases (29%) and one view in
7,090 (71%). For 46 cases (< 0.5%), the number of views
available was not recorded. Thus, analyses incorporating
number of views are based on 10,002 subjects rather than
10,048. Where only the mediolateral oblique (MLO) view was
available, there was a modest, borderline significant (P = 0.05)
effect of breast density on risk, with an OR for the highest cat-
egory relative to the lowest of 1.88 (95% CI = 0.80 to 4.45).
When two views were available, there was a considerably
stronger association (P < 0.001), with the corresponding OR
being 16.89 (95% CI = 2.13 to 133.87). The heterogeneity
between one view and two views of the association with risk
was significant (P = 0.002). The very wide 95% CIs in those
with two views are due to the fact that the reference category
Table 1
Number of subjects and mean density by diagnostic category
Diagnostic category Number of subjects Mean (SD) percent density
No cancer 9,737 33.1 (20.6)
Cancer at 1996 screen 82 42.9 (17.8)
Interval cancer < 1 year 7 50.3 (28.1)
Interval cancer 2 to 3 years 42 34.2 (22.0)
Cancer at subsequent screen 96 34.5 (21.2)
Cancer thereafter 84 42.4 (24.3)
Total 10,048 33.3 (20.7)
SD, standard deviation.
Table 2
Effect of categorized density on breast cancer risk by centre, age-adjusted
Population Percent breast density (%) Number (%) of cancers Number (%) of noncancers OR (95% CI) Significance (trend)
All subjects 0 to 10 18 (6) 1022 (11) 1.00 (-) P < 0.001
11 to 25 76 (24) 2997 (31) 1.43 (0.85 to 2.42)
26 to 50 117 (38) 3519 (36) 1.87 (1.13 to 3.11)
51 to 75 82 (26) 1875 (19) 2.44 (1.45 to 4.10)
76 to 100 18 (6) 324 (3) 3.07 (1.57 to 5.99)
Manchester 0 to 10 2 (1) 367 (7) 1.00 (-) P < 0.001
11 to 25 24 (18) 1397 (28) 3.14 (0.73 to 13.35)
26 to 50 60 (44) 2229 (44) 4.89 (1.18 to 20.08)
51 to 75 41 (30) 951 (19) 7.66 (1.83 to 31.93)
76 to 100 8 (6) 103 (2) 13.53 (2.81 to 65.10)
Aberdeen 0 to 10 16 (9) 655 (14) 1.00 (-) P = 0.12
11 to 25 52 (30) 1600 (34) 1.33 (0.75 to 2.35)
26 to 50 57 (32) 1290 (28) 1.80 (1.02 to 3.17)
51 to 75 41 (23) 924 (20) 1.80 (0.99 to 3.25)
76 to 100 10 (6) 221 (5) 1.82 (0.81 to 4.10)
CI, confidence interval; OR, odds ratio.
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of density, 0% to 10%, contained only one cancer. The differ-
ence in results remained strong when we merged the two low-
est density categories to include 0% to 25% density. The OR
for 76% to 100% density relative to 0% to 25% was 1.51
(95% CI = 0.71 to 3.18) when only the MLO view was availa-
ble, but it was 6.77 (95% CI = 2.75 to 16.67) when two views
were available.
Table 4 shows the distribution of cancers by detection mode,
and noncancers, for one-view and two-view cases separately.
Table 5 shows the mean and SD of density by centre, number
of views and cancer status, and the age-adjusted ORs associ-
ated with an increase of 10% in density. Population attributa-
ble fractions, for a reference level of 20% density, are also
shown. In Aberdeen the density determined using two views
(MLO and craniocaudal [CC]) was associated with risk of
breast cancer, whereas the one view (MLO only) was not. In
addition, where two views were available, the estimated aver-
age densities of the cancers and noncancers exhibited good
agreement between the two centres. The heterogeneity
between centres with respect to the density/risk association
was no longer significant when analysis was restricted to the
two-view mammograms (P = 0.4). The percentage of cases
estimated to be attributable to density in Aberdeen was much
closer to that of Manchester in the case of two views.
After exclusion of the 82 cancers detected at the evaluation
screen and the seven interval cancers diagnosed within 1 year
of the screen, the results were largely unchanged. The modify-
ing effect of number of views was still strong. For one-view
mammograms, the OR per 10% increase in density was 1.05
(95% CI = 0.98 to 1.14; P = 0.2). With two views, the OR was
1.33 (95% CI = 1.17 to 1.52; P < 0.001). Table 6 shows the
mutually adjusted effects of density, reader within centre and
age on risk, also excluding the evaluation screen cancers and
the interval cancers within 1 year. The effect of density is very
similar to the age-adjusted effect shown in Table 2 for all sub-
jects and cancers.
Discussion
Our results indicate that there is a strong association of visu-
ally assessed percent breast density with breast cancer risk,
but that the association is considerably more consistent when
two views are available. The magnitude of the association with
breast cancer risk is smaller than that observed using the inter-
active threshold software when only a single view is available,
but is comparable with that derived using the software when
assessed using two views [1,3]. In the latter case, a sixfold
increase in risk was observed in the 76% to 100% category
relative to the 0% to 25% category. The greater effect of den-
sity in Manchester is partly a reflection of the higher proportion
with two views in that centre (34% in Manchester versus 24%
in Aberdeen). The better risk prediction with two views may be
a reflection of better performance of an assessed average
density from the two views or it may be due to the CC view
alone. At any rate, the results emphasize the importance of the
CC view in visual assessment of breast density.
The readers were blind to the disease state of the screenees.
The cancers did, however, include 82 cases that had been
diagnosed at the screen pertinent to the mammograms read.
When these were excluded the results were largely
unchanged. When the interval cancers diagnosed within 12
months of the screen were also excluded, the results remained
the same.
Table 3
Association of categorised density with risk by number of views available
Percent breast density (%) Single view Two views
Number of cancers/subjects OR (95% CI) Number of cancers/subjects OR (95% CI)
0 to 10 17/794 1.00 (-) 1/241 1.00 (-)
11 to 25 67/2,322 1.33 (0.77 to 2.29) 9/736 2.99 (0.37 to 23.70)
26 to 50 91/2,567 1.64 (0.96 to 2.77) 26/1,052 6.16 (0.83 to 45.63)
51 to 75 54/1,222 1.97 (1.12 to 3.43) 28/727 9.79 (1.32 to 72.47)
76 to 100 8/185 1.88 (0.79 to 4.45) 10/156 16.89 (2.13 to 133.87)
Significance - P = 0.05 - P < 0.001
CI, confidence interval; OR, odds ratio.
Table 4
Number of views by detection mode
Detection mode One view (n [%]) Two view (n [%])
Noncancer 6,853 2,838
Prevalence screen 1 19
Interval cancer 101 32
Incidence screen 135 23
Total 7,090 7,090
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To investigate the possibility that the Manchester readers were
first identifying cancers and then involuntarily marking higher
densities, we estimated the association of density with risk in
Manchester excluding those cancer cases identified by the
reader. The results were similar to those using the entire
tumour population; for a 10% increase in density there was an
OR of 1.23 (95% CI = 1.09 to 1.39), excluding identified can-
cers; including all 311 cancers, the figure was 1.27 (95% CI
= 1.16 to 1.39).
It is interesting to note in Table 5 that where two views were
available, average estimated density was higher regardless of
centre, and was slightly greater for cancers than for noncan-
cers. Although we only have one percent density estimate per
subject, not separate scores for the MLO and CC views, this
result is consistent with the finding of Warren and coworkers
[13] that density estimates on the CC view tend to be higher
than on the MLO. It is possible that the MLO view includes
fatty tissue immediately in front of the chest wall, which is not
seen on the CC view, thus giving a lower percentage of dense
tissue in the MLO. Also, our observation that the highest aver-
age density was observed in women with interval cancers aris-
ing within 1 year of a negative screen is consistent with the
findings of Boyd and colleagues [1], who found that women
with greater than 75% density were 17.8 times more likely
than women with less than 10% density to develop breast can-
cer within 12 months of a negative screen. Our findings there-
fore suggest a genuine increase in risk, possibly artificially
augmented by a masking effect in interval cancers arising soon
after a screen.
It should be noted that the interactive threshold method will
avoid some of the subjectivity to which visual assessment is
prone. Also, the use of total dense area rather than percent
density in the interactive threshold method might show greater
consistency between subjects in its predictive potential. At
least one study has found that the total dense area is a better
predictor of risk [14], although the bulk of the published evi-
dence favours percent density [15-19].
It is worth noting that availability of two views was highly con-
founded with whether the screen was a prevalent or incident
screen. Of the prevalent screens 99% were two view, and only
3% of the incident screens were two view. The same percent-
ages apply to the cancers. This is because in the National
Screening Programme in 1997, the policy was to use two-
view mammography at the prevalent screen and single-view
thereafter. The policy has since been changed to two views as
standard at all screens. This indicates that the number of views
was determined by the prevalent/incident status of the screen
and not by clinical or radiological considerations. Analysis
restricted to two-view screens yielded a stronger effect of den-
sity on cancer risk than did analysis restricted to prevalent
screens. This suggests that the number of views is the factor
responsible for the performance of visually assessed density in
predicting risk, rather than the order of screen. Similarly, con-
founding with age did not explain the heterogeneity by number
of views.
Table 5
Association of continuous density with risk, by centre and number of views available
Centre Number of 
views
Number of 
subjects
Mean (SD) density, 
cancers
Mean (SD) density, 
noncancers
OR per 10% density 
(95% CI)
% attributable fraction 
to densities > 20%
Manchester 1 3,416 39.8 (18.5) 32.2 (17.5) 1.22 (1.09 to 1.36) 3
2 1,721 51.1 (19.7) 37.4 (19.7) 1.41 (1.19 to 1.66) 35
Aberdeen 1 3,674 32.2 (21.1) 30.6 (21.8) 1.03 (0.95 to 1.11) 30
2 1,191 52.0 (24.0) 36.8 (24.4) 1.28 (1.11 to 1.46) 50
CI, confidence interval; OR, odds ratio; SD, standard deviation.
Table 6
Multivariate model of breast cancer risk including density, 
reader/centre and age, excluding cancers diagnosed at or 
within 1 year of the evaluation screen
Risk factor Category OR (95% CI)
Percent density (%) 0 to 10 1.00 (-)
11 to 25 1.26 (0.73 to 2.15)
26 to 50 1.84 (1.06 to 3.19)
51 to 75 2.09 (1.17 to 3.72)
76 to 100 2.97 (1.41 to 6.26)
Reader Aberdeen 1 1.00 (-)
2 0.78 (0.43 to 1.39)
3 1.85 (1.10 to 3.09)
4 2.04 (1.25 to 3.33)
Reader Manchester 5 0.68 (0.36 to 1.29)
6 1.04 (0.61 to 1.76)
7 0.79 (0.45 to 1.40)
8 0.52 (0.27 to 1.00)
Age Per year 0.98 (0.95 to 1.02)
CI, confidence interval; OR, odds ratio.
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Although breast density remains a highly important risk factor
for breast cancer, the question of whether alteration of density,
particularly percentage density, in an individual will necessarily
alter that individual's future breast cancer risk remains open.
Patel and coworkers [20], using both an automated volumetric
method and a visually estimated percentage of glandular tis-
sue, found that changes in weight resulted in dramatic differ-
ences to the percentage density but little difference in the
absolute volume of fibroglandular tissue.
Nevertheless, it is increasingly clear that mammographic den-
sity has considerable potential in risk assessment to select
high-risk populations or for early detection or prevention
projects and programme policies. There is evidence that den-
sity measured by the Cumulus interactive threshold software
is a better predictor of risk than density assessed visually [3].
The scanning and processing of the mammographic images
and the subsequent operation of the software add up to a
major commitment of resources.
It should be noted that important confounders of density such
as body mass index and various hormonal breast cancer risk
factors were not available. It is likely that had we been able to
adjust for body mass index, the relation of density to risk would
have been stronger [3]. Differences in body mass or other risk
factor prevalences might also explain some of the difference in
levels of density in the two centres, but they would be unlikely
to explain the difference in the association with risk or the mod-
ifying effect of number of views.
Conclusion
The results here suggest that a predictive power similar to that
of Cumulus can be derived from visually assessed density if
the CC view is available. There is, however, a need to study
this question with independent estimation of density in the
same subjects, using four methods: the Cumulus software;
visually assessed density from a MLO view alone; visually
assessed density from the CC view alone; and visually
assessed density from a MLO plus CC views.
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